NCT05662189View on ClinicalTrials.gov

Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions
Type1diabetesType2diabetesPre DiabetesHyperinsulinism
Interventions
DRUG

68Ga-exendin-4

68Ga-exendin4 PET-CT scan

OTHER

mixed meal test

before and after a standardized mixed meal venous blood samples will be collected at time intervals to measure plasma glucose, C-peptide,insulin, glucagon, glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) curves

Trial Locations (1)

43126

RECRUITING

Azienda Ospedaliero Universitaria di Parma, Parma

All Listed Sponsors
collaborator

University of Parma

OTHER

lead

Azienda Ospedaliero-Universitaria di Parma

OTHER